Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (US20130053437) Anti-inflammatory compounds

Application Number: 13509194 Application Date: 10.11.2010
Publication Number: 20130053437 Publication Date: 28.02.2013
Grant Number: 09403786 Grant Date: 02.08.2016
Publication Kind : B2
Prior PCT appl.: Application Number:PCTAU2010001502 ; Publication Number: Click to see the data
IPC:
C07D 307/42
C07D 307/54
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
307
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
02
not condensed with other rings
34
having two or three double bonds between ring members or between ring members and non-ring members
38
with substituted hydrocarbon radicals attached to ring carbon atoms
40
Radicals substituted by oxygen atoms
42
Singly bound oxygen atoms
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
307
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
02
not condensed with other rings
34
having two or three double bonds between ring members or between ring members and non-ring members
38
with substituted hydrocarbon radicals attached to ring carbon atoms
54
Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applicants: Susan J. Semple
University of South Australia
Bradley S. Simpson
Chuulangun Aboriginal Corporation
Ross Allan McKinnon
David Claudie
Jacobus P. Gerber
Jiping Wang
George Moreton, Sr.
Inventors: Susan J. Semple
Bradley S. Simpson
Ross Allan McKinnon
David Claudie
Jacobus P. Gerber
Jiping Wang
George Moreton, Sr.
Agents: Olson & Cepuritis, Ltd.
Priority Data: 2009905498 10.11.2009 AU
Title: (EN) Anti-inflammatory compounds
Abstract: front page image
(EN)

New clerodane compounds isolated from plant material from Dodonaea polyandra are disclosed. The compounds have anti-inflammatory activity. Pharmaceutical and cosmetic compositions containing the compounds, as well as methods of treating inflammation using the compounds, are also disclosed.